Longevity at Edge City Lanna
UPDATE: As mentioned in the mail, the venue for Friday is Khoy and the event starts at 2 pm.
https://maps.app.goo.gl/m4Us3oREjiAEyxuW6
Saturday and Sunday events during the day will be in A-Ter. Saturday the event starts at 10am and Sunday at 11am.
https://g.co/kgs/mNbGhNX
Evening events on the weekend will be in Red Dog Gallery:
26 Charoen Muang Rd, Tambon Chang Moi, Mueang Chiang Mai District
Public telegram group for the event: https://t.me/+Msocbod8NLE3MmM6
Longevity biotech (LongBio) is the future of medicine.
Rejuvenation biotech has already extended healthy lifespans of mice by >50%. The traditional pharma sector is slow and focused on the old model, leading to us building a longevity biotech movement.
The greatest threat to any individual, as well as society from social and economic angles, is biological aging. Aging has killed almost everyone throughout history, and caused a lot of suffering on the way down. Now, the global demographic aging crisis ("Silver Tsunami") threatens to collapse the ponzi economics of legacy governments.
Learn about the latest developments in the LongBio field, the future of gene and cell therapy, and discuss biohacking interventions currently in use.
The larger pop-up city of Edge City Lanna: https://www.edgecity.live/lanna
Topics
The series of events will run on 3 tracks:
Small Molecules and Biohacking (applied science on Friday, October 18 and basic research on Saturday, October 19)
Big Data and AI (Saturday, October 19)
Investing in Longevity (Sunday, October 20)
Sponsors
We thank our sponsors:
Speakers Bio
"Building and Investing In Longevity Biotech (LongBio) and the Future of Medicine" - Sebastian Brunemeier
Sebastian Brunemeier, Biotech VC and company builder focused on longevity & regenerative medicine. Founder & CEO of ImmuneAGE Bio, General Partner at Healthspan Capital, co-founder and CIO of Cambrian Biopharma, Founder & COO of Samsara Therapeutics, Principal at Apollo Health Ventures. Longevity scientist by training, ex-University of Oxford and University of Amsterdam.
"Hacking Aging using Big Data and AI" - Peter Fedichev (Gero AI)
Peter Fedichev, Ph.D., is an entrepreneur and scientist with over 20 years of experience in academic research and biotech business. He is a founder of Gero, a longevity startup focused on developing therapies that will extend a healthy human lifespan. Peter’s scientific background lies in the field of condensed matter physics, biophysics and bioinformatics. He has conducted research at Kurchatov Institute, one of the leading science government agencies in Russia, AMOLF, an academic institute for fundamental physics in the Netherlands, and the University of Innsbruck. Peter earned his M.S. in theoretical physics from the Moscow Institute of Physics and Technology and his Ph.D. from the University of Amsterdam.
"Aging clocks - towards robust measures" - Prof. Jan Gruber (National University of Singapore)
Jan Gruber is a physicist turned aging researcher and an Associate Professor at Yale-NUS. Before his appointment, he was a Senior Research Fellow in the Neurobiology and Ageing Programme at the Centre for Life Sciences (CeLS), National University of Singapore (NUS).
"Nutritional small molecules and supplements for healthy aging" - Dr. Dushani L. Palliyaguru (HealthSurveil)
During her PhD, Dushani Palliyaguru worked on liver disease and cancer prevention using nutritional and natural compounds --specifically, the Nrf2-mediated environmental stress response pathway. Subsequently, she was a fellow at the National Institute on Aging focusing on biomarkers of aging and now she wants to apply her knowledge in the real world.
"Hybrid Approaches to Substantially Slow or Reverse Aging" - Kamil Pabis (National University of Singapore, VitaDAO)
Kamil Pabis, MSc, is a longevity researcher at the National University of Singapore. He is also a science blogger and podcaster (supported by VitaDAO), as well as a community leader in Singapore who works towards strengthening the pan-Asian longevity community. Research focus includes mouse lifespan studies, small molecules, and theoretical approaches.
"From Video Game Founder to Longevity Investor - Our War against the Dragon-Tyrant" - Wang Boyang (immortal dragons)
"Lessons from the nuclear periphery for human health & disease" — Oliver Dreesen
Dr. Oliver Dreesen is a Senior Principal Investigator and Head of the Laboratory for Cell Aging at the Agency for Science, Technology & Research（A*STAR）in Singapore. He served as President of the Skin Research Society (Singapore) from 2019-2021.
"Compliance and confusion in longevity" — Shantanu Kumar
Shantanu Kumar is building global consumer brands in beauty and wellness. He runs Xandro labs, a dietary supplements brand, and Cerm, a youth centered skincare brand. He leverages performance marketing and distribution channels to scale DTC brands.
"Using nematode worms to solve aging" — Jan Gruber
Prof. Jan Gruber is currently an Associate Professor at Yale-NUS, with a demonstrated history in leading independent biomedical research and higher education. Research interest in ageing, mitochondria, pharmacological interventions, biological ageing clocks and tools for modelling of mechanisms of ageing and disease.
"From high school to investing in longevity" — Denisa Lepadatu
Denisa Lepadatu is an advisor for a longevity-focused VC fund, Apollo Health Ventures, and a founder of LongX, organization offering longevity education and opportunities worldwide. She has a background in biochemistry and cell biology and acts as a project and event organizer for multiple pop-up cities.
"Hacking Aging using Big Data and AI" — Peter Fedichev
Peter Fedichev is a scientist and entrepreneur with over 20 years of experience in academic research and the biotech industry. Currently, I serve as the CEO of Gero.ai, company that developed proprietary physics-based machine learning models, known as Large Health Models (LHMs), to analyze human health data and predict health outcomes. His scientific background lies at the intersection of physics and biology, with specific expertise in condensed matter physics, biophysics, and bioinformatics.
"Journal club: how to read a bioinformatics paper" — Kirill Denisov
Kirill Denisov is a Middle Researcher at Gero.ai. In his role, he leverages deep learning, mathematical modeling, and medical genetics.
"Putting individuals in the economic driver seat of their health Journey" — Jean-Philippe Diel
Jean-Philippe Diel is the founder of SymbionIQ Labs and The SymbionIQ Foundation, developing innovative solutions to empower individuals with control over their health data and incentivize behaviors that promote longevity. His experience spans Consumer Technology marketing (hardware and software), FMCG, and entrepreneurship.
"Unlocking Longevity: Bridging science with clinical practice" — Hisham Badaruddin
Dr. Hisham Badaruddin is a certified longevity medicine physician and public health specialist. He is the Founder of Bartley Clinic, a primary care clinic that offers personalized longevity medicine focusing on optimising healthspan and lifespan.
"Shifting the Overton Window on Radical Life Extension Therapies" — Alice Gilman
Alice Gilman is a Chief of Staff for a stealth experimental stem cell based startup aimed at transforming the medical industry and delay aging.
"Fundraising from a founder's perspective" — Boris Djordjevic
Boris Djordjevic is the CEO of 199 Biotechnologies, a cutting-edge startup founded in 2023 focused on developing clinical products based on epigenetic reprogramming to tackle chronic and age-related diseases by targeting the hallmarks of aging.
"Applying synthetic biology to treat the hallmarks of aging" - Yu YoSean Wang (DeSci Sino, Co-Initiator & Community Operator). Longevity investor.
"Drugs to improve female fertility and aging" — Lan Xi
Lan Xi has done research on stem cell differentiation, xenopus and intestinal organoid development and mouse reproduction, currently under the National University of Singapore Graduate School.
Virtual recordings
These will be screened throughout the week in the The-A-Ter at dedicated times.
Michael Ringel, PhD has been at the Boston Consulting Group (BCG) for 25 years and is currently Managing Director and Senior Partner. He is on the Board of Hevolution US, the charitable organization focused on extending healthy aging for the benefit of all humanity, the Board of AFAR, one of the oldest organizations supporting healthy aging through biomedical research, and on the Executive Board of the Sheba Longevity Center, a clinic at one of the world's best hospitals devoted to healthy aging.
Aubrey de Grey PhD, Founder of the LEV Foundation, author of Ending Aging, and the world’s most prominent proponent of rejuvenation biotech.
Prof Terence Kealey PhD: Former Vice-Chancellor of the University of Buckingham, Professor of Clinical Biochemistry. Former biochemistry Lecturer at the University of Cambridge. PhD at University of Oxford. He has made the libertarian case against government funding of science — due to the 'crowding out' effect and inherent inefficiencies and dogmatism of bureaucratic centralization. He published around 45 original peer‐reviewed papers and around 35 scientific reviews.
Prof Jessica Flanigan, PhD: Professor of Healthcare Ethics at University of Richmond, author of “Pharmaceutical Freedom: Why Patients Have A Right to Self Medicate” (Oxford University Press).
Yuta Lee founded Accelerated Biosciences Corp commercialize the pluripotent human trophoblast stem cell (hTSC) platform. His father, Professor Jau-Nan Lee, had isolated and characterized hTSC in 2003. To date, Accelerated Biosciences has been awarded 49 patents worldwide. Yuta also served as the President of ZMI Electronics, a Taiwan based medical device company.
Natalie Coles is Chief Biosampler at R3 Bio and Project Manager for their supercentenarian biobank. Her experience includes 16 years of phlebotomy, focused on the world’s oldest people, as well as serving as assistant transplant coordinator in UCLA’s departments of face and limb (for military veterans), liver (adult, pre and post transplant), and multivisceral transplant for both pediatric and adult patients. She also served as chief phlebotomist for multiple supercentenarian projects.
Tristan Roberts (Fmr Co-Founder of Minicircle, advisor to BioFoundry & Unlimited Bio in Vitalia/Prospera). He'll be speaking on "Frontier Science in Special Economic Zones".
Adam Gries, Co-Founder of Vitalism: The revolutionary movement to solve biological aging and death. Adam is a 4x founder, angel investor, and longevity advocate. He has built products reaching 80+ million users. Adam holds a B.Sc in Neuroscience.